NHCNYSEServices-Skilled Nursing Care FacilitiesFiscal year ends December 31
NATIONAL HEALTHCARE CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$239.24−3.58 (-1.47%)
Close on Oct 19, 2026
- Market cap
- $3.80B
- P/E (TTM)
- 26.9
- Dividend yield
- 1.06%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
65.3%
10M of 16M shares
Institutional holders
248
39 new, 26 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
1 buys · 23 sales
Net sold $10.98M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dimensional Fund Advisors LP | 957,815 | 6.30% | 13G (passive) amendment | Dec 29, 2023 |
| First Trust Portfolios L.P. | 795,771 | 5.09% | 13G (passive) | Jun 30, 2026 |
| Vanguard Portfolio Management | 794,305 | 5.11% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 1,800,345 | 11.60% | 13G (passive) amendment | Sep 30, 2025 |
| Morgan Stanley | 1,102,537 | 7.10% | 13G (passive) amendment | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,975,785 | 12.62% | $417.60M | +80,535 | 0.01% |
| Morgan Stanley Institutional Investment Advisors LLC | 1,028,534 | 6.57% | $217.39M | −10,270 | 20.31% |
| Dimensional Fund Advisors LP | 929,692 | 5.94% | $196.49M | −17,285 | 0.04% |
| Vanguard Portfolio Management LLC | 809,224 | 5.17% | $171.04M | +19,803 | 0.01% |
| First Trust Advisors LP | 730,573 | 4.66% | $154.41M | +200,271 | 0.09% |
| Vanguard Capital Management LLC | 552,136 | 3.53% | $116.70M | +2,588 | 0.00% |
| State Street Corp | 526,732 | 3.36% | $111.68M | +35,157 | 0.00% |
| Geode Capital Management, LLC | 380,934 | 2.43% | $80.53M | +57,667 | 0.00% |
| Renaissance Technologies LLC | 299,717 | 1.91% | $63.35M | −35,800 | 0.09% |
| Invesco Ltd. | 175,290 | 1.12% | $37.05M | +25,094 | 0.00% |
| Charles Schwab Investment Management Inc | 174,335 | 1.11% | $36.85M | −4,263 | 0.00% |
| Northern Trust Corp | 145,179 | 0.93% | $30.69M | +8,468 | 0.00% |
| Bank of New York Mellon Corp | 122,320 | 0.78% | $25.85M | +2,367 | 0.00% |
| Systematic Financial Management LP | 109,086 | 0.70% | $23.06M | −7,162 | 0.46% |
| T. Rowe Price Investment Management, Inc. | 107,248 | 0.68% | $22.67K | New | 0.01% |
| Arrowstreet Capital, Limited Partnership | 96,550 | 0.62% | $20.41M | +21,293 | 0.01% |
| Morgan Stanley | 93,536 | 0.60% | $19.77M | −14,276 | 0.00% |
| American Century Companies Inc | 92,933 | 0.59% | $19.64M | +3,317 | 0.01% |
| Alps Advisors Inc | 87,660 | 0.56% | $18.53M | −70,180 | 0.09% |
| Vanguard Fiduciary Trust Co | 84,971 | 0.54% | $17.96M | +4,802 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 248 | 10M | 65.3% | 39 / 93 | 75 / 26 | 1M | 1M |
| Q1 2026 | 239 | 10M | 66.1% | 45 / 76 | 77 / 23 | 2M | 0M |
| Q4 2025 | 222 | 10M | 63.8% | 34 / 74 | 77 / 17 | 1M | 0M |
| Q3 2025 | 207 | 10M | 61.3% | 38 / 61 | 72 / 21 | 1M | 0M |
| Q2 2025 | 190 | 9M | 57.5% | 32 / 63 | 65 / 19 | 0M | 0M |
| Q1 2025 | 179 | 9M | 57.9% | 20 / 64 | 68 / 23 | 0M | 1M |
| Q4 2024 | 185 | 9M | 58.6% | 19 / 62 | 72 / 28 | 0M | 0M |
| Q3 2024 | 194 | 9M | 59.4% | 35 / 62 | 66 / 14 | 3M | 0M |
| Q2 2024 | 175 | 8M | 54.2% | 25 / 60 | 66 / 19 | 0M | 0M |
| Q1 2024 | 170 | 9M | 55.0% | 31 / 42 | 70 / 20 | 1M | 1M |
| Q4 2023 | 159 | 9M | 56.7% | 40 / 47 | 57 / 11 | 2M | 1M |
| Q3 2023 | 131 | 7M | 47.0% | 11 / 41 | 55 / 12 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 752,952 | 4.81% | $159.14M | 0.14% | Jun 30, 2026 |
| First Trust SMID Cap Rising Dividend Achievers ETF | 636,492 | 4.06% | $134.53M | 1.19% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 396,172 | 2.53% | $83.73M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 333,531 | 2.13% | $70.50M | 0.08% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 286,336 | 1.83% | $60.52M | 0.03% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 193,388 | 1.23% | $43.71M | 0.22% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 181,535 | 1.16% | $38.37M | 0.06% | Jun 30, 2026 |
| ALPS | OShares U.S. Small-Cap Quality Dividend ETF | 153,397 | 0.98% | $28.29M | 3.23% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 143,030 | 0.91% | $30.23M | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 142,177 | 0.91% | $32.14M | 0.09% | Jul 31, 2026 |
| U.S. Targeted Value Portfolio | 128,627 | 0.82% | $29.07M | 0.17% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 115,008 | 0.73% | $24.31M | 0.14% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 112,293 | 0.72% | $23.73M | 0.29% | Jun 30, 2026 |
| Invesco S&P SmallCap Momentum ETF | 111,575 | 0.71% | $25.22M | 0.83% | Jul 31, 2026 |
| Dimensional U.S. Targeted Value ETF | 93,924 | 0.60% | $21.23M | 0.15% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Stephen Fowler Flatt | CEO, Director | 65,487 | 0.42% | Aug 20, 2026 |
| Vicki L. Dodson | Sr.VP Patient Srvcs | 10,726 | 0.07% | Sep 23, 2026 |
| Josh A. McCreary | Senior VP & General Counsel | 9,979 | 0.06% | Sep 14, 2026 |
| Brian F. Kidd | SVP, CFO | 23,183 | 0.15% | Sep 14, 2026 |
| Ben Anderson Flatt Sr | Senior VP & CIO | 15,636 | 0.10% | Sep 2, 2026 |
| Timothy J. Shelly | Sr.VP Operations | 1,294 | 0.01% | May 20, 2026 |
| Robert Michael Ussery | President & COO | 158,460 | 1.01% | Jan 5, 2026 |
| David R. Gifford | Director | 1,030 | 0.01% | Aug 28, 2026 |
| Emil E. Hassan | Director | 65,595 | 0.42% | Jun 23, 2026 |
| Robert G. Adams | Director | 443,920 | 2.83% | Jun 10, 2026 |
| Lisa Piercey | Director | 949 | 0.01% | Jun 2, 2026 |
| Richard F. Laroche Jr | Director | 301,760 | 1.93% | May 22, 2026 |
| Sandra Y. Trail | Director | 10,640 | 0.07% | May 8, 2026 |
| William A. Adams | Director | – | – | May 8, 2026 |
| James Paul Abernathy | Director | 43,302 | 0.28% | May 7, 2026 |
| W. Andrew Adams | Director | 304,979 | 1.95% | May 6, 2025 |
| Health Corp National | – | 1,030,887 | 6.58% | Jan 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Vicki L. Dodson Sr.VP Patient Srvcs | Sep 22, 2026 | Sale | −4,834 | $225.00 | $1.09M | 10,726 |
| Brian F. Kidd SVP, CFO | Sep 11, 2026 | Sale | −6,813 | $225.70 | $1.54M | 23,183 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −68 | $225.59 | $15.34K | 9,979 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −571 | $222.73 | $127.18K | 12,127 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −789 | $223.78 | $176.56K | 11,338 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −1,291 | $225.09 | $290.59K | 10,047 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 28, 2026 | Sale | −1,000 | $222.50 | $222.50K | 15,636 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 25, 2026 | Sale | −1,000 | $227.00 | $227.00K | 16,636 |
| David R. Gifford Director | Aug 25, 2026 | Sale | −1,779 | $225.42 | $401.02K | 1,030 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 20, 2026 | Sale | −1,000 | $237.00 | $237.00K | 17,636 |
| David R. Gifford Director | Aug 20, 2026 | Option exercise | +6,479 | $171.42 | $1.11M | 7,500 |
| David R. Gifford Director | Aug 20, 2026 | Award | −4,691 | $236.75 | $1.11M | 2,809 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 19, 2026 | Sale | −1,000 | $237.18 | $237.18K | 18,636 |
| Stephen Fowler Flatt CEO, Director | Aug 19, 2026 | Sale | −1,500 | $237.08 | $355.62K | 65,487 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 17, 2026 | Sale | −1,000 | $226.00 | $226.00K | 19,636 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 14, 2026 | Sale | −1,000 | $222.11 | $222.11K | 20,636 |
| David R. Gifford Director | Aug 13, 2026 | Option exercise | +1,021 | $171.42 | $175.02K | 1,021 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 12, 2026 | Sale | −1,000 | $221.21 | $221.21K | 21,636 |
| Emil E. Hassan Director | Jun 22, 2026 | Sale | −5,937 | $200.00 | $1.19M | 65,595 |
| Emil E. Hassan Director | Jun 16, 2026 | Sale | −1,563 | $199.98 | $312.57K | 71,532 |
| Brian F. Kidd SVP, CFO | Jun 16, 2026 | Gift | −500 | – | – | 29,996 |
| Robert G. Adams Director | Jun 8, 2026 | Gift | −4,000 | – | – | 13,579 |
| Robert G. Adams Director | Jun 8, 2026 | Option exercise | +4,000 | $69.19 | $276.76K | 17,579 |
| Lisa Piercey Director | Jun 1, 2026 | Buy | +949 | $184.26 | $174.86K | 949 |
| Ben Anderson Flatt Sr Senior VP & CIO | May 22, 2026 | Option exercise | +4,000 | $94.10 | $376.40K | 25,375 |
| Ben Anderson Flatt Sr Senior VP & CIO | May 22, 2026 | Tax withholding | −2,739 | $196.00 | $536.84K | 22,636 |
| Richard F. Laroche Jr Director | May 21, 2026 | Sale | −7,500 | $195.14 | $1.46M | 205,760 |
| Stephen Fowler Flatt CEO, Director | May 20, 2026 | Gift | −26 | – | – | 66,987 |
| Timothy J. Shelly Sr.VP Operations | May 19, 2026 | Sale | −1,853 | $197.22 | $365.45K | 1,294 |
| Stephen Fowler Flatt CEO, Director | May 14, 2026 | Tax withholding | −4,492 | $197.96 | $889.24K | 67,013 |
| Stephen Fowler Flatt CEO, Director | May 14, 2026 | Option exercise | +1,000 | $90.62 | $90.62K | 71,505 |
| Stephen Fowler Flatt CEO, Director | May 14, 2026 | Option exercise | +5,000 | $94.10 | $470.50K | 70,505 |
| Brian F. Kidd SVP, CFO | May 14, 2026 | Tax withholding | −3,134 | $197.96 | $620.41K | 30,496 |
| Brian F. Kidd SVP, CFO | May 14, 2026 | Option exercise | +500 | $90.62 | $45.31K | 33,630 |
| Brian F. Kidd SVP, CFO | May 14, 2026 | Option exercise | +4,000 | $94.10 | $376.40K | 33,130 |
| Sandra Y. Trail Director | May 6, 2026 | Option exercise | +3,140 | $55.75 | $175.06K | 10,640 |
| Richard F. Laroche Jr Director | May 5, 2026 | Option exercise | +7,500 | $71.64 | $537.30K | 213,260 |
| Emil E. Hassan Director | Apr 30, 2026 | Option exercise | +7,500 | $71.64 | $537.30K | 73,095 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Apr 22, 2026 | Option exercise | +4,000 | $94.10 | $376.40K | 18,413 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Apr 22, 2026 | Tax withholding | −2,853 | $173.63 | $495.37K | 15,560 |
| Ben Anderson Flatt Sr Senior VP & CIO | Apr 9, 2026 | Tax withholding | −2,109 | $176.81 | $372.89K | 21,175 |
| Ben Anderson Flatt Sr Senior VP & CIO | Apr 9, 2026 | Tax withholding | −1,909 | $176.81 | $337.53K | 21,375 |
| Ben Anderson Flatt Sr Senior VP & CIO | Apr 9, 2026 | Option exercise | +3,734 | $53.94 | $201.41K | 23,284 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 16, 2026 | Tax withholding | −2,034 | $164.96 | $335.53K | 14,413 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 16, 2026 | Option exercise | +3,734 | $53.94 | $201.41K | 16,447 |
| Brian F. Kidd SVP, CFO | Mar 12, 2026 | Option exercise | +1,853 | $53.94 | $99.95K | 29,130 |
| Stephen Fowler Flatt CEO, Director | Mar 12, 2026 | Option exercise | +1,853 | $53.94 | $99.95K | 65,505 |
| James Paul Abernathy Director | Mar 9, 2026 | Option exercise | +3,140 | $55.75 | $175.06K | 43,302 |
| Josh A. McCreary Senior VP & General Counsel | Mar 4, 2026 | Tax withholding | −3,202 | $172.83 | $553.40K | 12,698 |
| Josh A. McCreary Senior VP & General Counsel | Mar 4, 2026 | Option exercise | +4,500 | $90.62 | $407.79K | 15,900 |
| Timothy J. Shelly Sr.VP Operations | Mar 4, 2026 | Option exercise | +3,667 | $90.62 | $332.30K | 7,628 |
| Timothy J. Shelly Sr.VP Operations | Mar 4, 2026 | Option exercise | +2,667 | $94.10 | $250.96K | 3,961 |
| Timothy J. Shelly Sr.VP Operations | Mar 4, 2026 | Tax withholding | −4,481 | $172.83 | $774.45K | 3,147 |
| Brian F. Kidd SVP, CFO | Mar 4, 2026 | Tax withholding | −3,947 | $172.83 | $682.16K | 27,277 |
| Brian F. Kidd SVP, CFO | Mar 4, 2026 | Option exercise | +2,000 | $53.94 | $107.88K | 27,224 |
| Brian F. Kidd SVP, CFO | Mar 4, 2026 | Option exercise | +4,000 | $90.62 | $362.48K | 31,224 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 4, 2026 | Option exercise | +4,500 | $90.62 | $407.79K | 15,872 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 4, 2026 | Tax withholding | −3,159 | $172.83 | $545.97K | 12,713 |
| Ben Anderson Flatt Sr Senior VP & CIO | Mar 4, 2026 | Tax withholding | −8,142 | $172.83 | $1.41M | 19,550 |
| Ben Anderson Flatt Sr Senior VP & CIO | Mar 4, 2026 | Option exercise | +4,500 | $90.62 | $407.79K | 27,692 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Josh A. McCreary Officer | Sep 10, 2026 | 2,719 | $600.82K | Sep 10, 2026 | Restricted Stock Vesting |
| F. LaRoche Richard Director | May 21, 2026 | 7,500 | $1.46M | May 21, 2026 | Options Exercise |
| Health Corporation (NHC) National Affiliate | Dec 27, 2024 | 55,000 | $6.11M | Dec 20, 2024 | Corporate Restructuring |
| James Paul Abernathy Director | Aug 13, 2024 | 1,605 | $195.81K | Aug 13, 2024 | Stock Option Grant of 6-2-10 |
| James Paul Abernathy Director | Aug 4, 2023 | 1,550 | $92.66K | Aug 14, 2023 | Exercise Stock Option, Granted 6/2/2016 |